[Case of autonomic hyperreflexia treated with intravenous nicardipine]
Junichi Saito1, Futoshi Kimura, Hironori Ishihara
1Department of Anesthesiology, Hirosaki University School of Medicine, Hirosaki 036-8562.
Abstract:
We describe a case of 26-year-old male patient with autonomic hyperreflexia (AH) during colostomy. He had suffered paraplegia due to the 8th cervical spinal cord injury by a traffic accident 2 years before. The anesthesia was induced and maintained with propofol, fentanyl, ketamine and vecuronium. Vital signs including blood pressure (135-145/70-80 mmHg) and heart rate (55-65 beats x min(-1)), were stable at the beginning of the operation. However, blood pressure suddenly rose (220/ 120mmHg), and heart rate decreased (43 beats x min(-1)) associated with skin eruptions on his face and shoulder when the intestinal tract procedure was started. Diagnosis of AH was made. Then nicardipine 1 mg i.v. was given followed by nicardipine 2 microg x kg(-1) x min(-1) DIV Consequently, blood pressure (140-155/ 70-85 mmHg) and heart rate (75-85 beats x min(-1)) were stabilized. The operation was finished with no evidence of any complications. Nicardipine may be preferable in a patient with upper spinal cord injury undergoing operation in the paralyzed area.
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Cardiac Catheterization IV: Nursing Management
Depolarizing Blockers: Pharmocokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Antihypertensive Drugs: Vasodilators
Cardiopulmonary Resuscitation IV: Pharmacological Management

